Clinical trial
Coload Optimization Guided by Inferior Vena Cava Collapsibility Index in Parturients With Prophylactic Norepinephrine Infusion Undergoing Cesarean Section: a Randomized, Dose-finding Trial
NCT04272632 is registered in ClinicalTrials.gov with General Hospital of Ningxia Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Coload Optimization Guided by Inferior Vena Cava Collapsibility Index in Parturients With Prophylactic Norepinephrine Infusion Undergoing Cesarean Section: a Randomized, Dose-finding Trial
- Lead sponsor
- General Hospital of Ningxia Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2021
- Completion date
- November 25, 2021
- Enrollment
- 168 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adverse effect